IP Verse

Exosomes For Delivery Of Biotherapeutics - EP2788019

The patent EP2788019 was granted to Isis Innovation on Apr 5, 2017. The application was originally filed on Dec 7, 2012 under application number EP12799264A. The patent is currently recorded with a legal status of "Revoked".

EP2788019

ISIS INNOVATION
Application Number
EP12799264A
Filing Date
Dec 7, 2012
Status
Revoked
Sep 3, 2021
Grant Date
Apr 5, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TRUSCOTTJan 5, 2018ADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2010119256
INTERNATIONAL-SEARCH-REPORTWO2010119256
INTERNATIONAL-SEARCH-REPORTWO2010141716
OPPOSITIONAU2004203482
OPPOSITIONUS2004028692
OPPOSITIONUS2004197314
OPPOSITIONWO2010119256
OPPOSITIONWO2010141716

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Ratna Chakrabarti; Wylie Dwane E; Schuster Sheldon M, "Transfer of monoclonal antibodies into mammalian cells by electroporation", J Biol Chem., (19890915), vol. 264, no. 26, pages 15494 - 15500, XP055202621-
OPPOSITION- BADER AG et al., "Developing therapeutic microRNAs for cancer", Gene Therapy, (20111200), vol. 18, no. 12, pages 1121 - 1126, XP055453917
OPPOSITION- HOLLIGER P et al., "Engineered antibody fragments and the rise of single domains", Nature Biotechnology, (20050901), vol. 23, no. 9, pages 1126 - 1136, XP008076746
OPPOSITION- ALVAREZ-ERVITI L et al., "Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes", Nature Biotechnology, (20110400), vol. 29, no. 4, pages 341 - 345, XP055227686
OPPOSITION- RATACJZAK et al., "Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery", LEUKEMIA, (20060501), vol. 20, no. 5, pages 847 - 856, XP002531347
OPPOSITION- PONSAERTS P; BERNEMAN Z N, "Modulation of cellular behavior by exogenous messenger RNA", LEUKEMIA, (20060501), vol. 20, no. 5, pages 767 - 769, XP002544196
OPPOSITION- QAZI et al., "Antigen-loaded exosomes alone induce Th1-type memory through a B- cell - dependent mechanism", Blood, (20090319), vol. 113, no. 12, pages 2673 - 2683, XP002607761
OPPOSITION- LOGOZZI M et al., "High Levels of Exosomes Expressing CD 63 and Caveolin-1 in Plasma of Melanoma Patients", PLoS ONE, (20090401), vol. 4, no. 4, pages 1 - 10, XP002527287

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents